A detailed history of Td Waterhouse Canada Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 7,230 shares of IMCR stock, worth $207,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,230
Previous 882 719.73%
Holding current value
$207,211
Previous $32.1 Million 602.04%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.06 - $41.49 $190,820 - $263,378
6,348 Added 719.73%
7,230 $226 Million
Q2 2024

Nov 12, 2024

BUY
$33.78 - $63.75 $4,492 - $8,478
133 Added 17.76%
882 $32.1 Million
Q1 2024

May 10, 2024

BUY
$60.14 - $75.36 $45,044 - $56,444
749 New
749 $47.5 Million

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.26B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.